WWW.EXFILE.COM, INC. -- 888-775-4789 -- BOSTON SCIENTIFIC CORP. -- FORM 8-K


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549



FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
 



Date of Report (Date of earliest event reported): May 20, 2009

BOSTON SCIENTIFIC CORPORATION
(Exact name of registrant as specified in charter)

DELAWARE
1-11083
04-2695240
(State or other
(Commission
(IRS employer
jurisdiction of
file number)
identification no.)
incorporation)
   

One Boston Scientific Place, Natick, Massachusetts
01760-1537
(Address of principal executive offices)
(Zip code)

Registrant’s telephone number, including area code:   (508) 650-8000

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the fling obligation of the registrant under any of the following provisions:

¨
Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
¨
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
¨
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))





 
 
 

ITEM 5.02.
DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS.

On May 20, 2009, Kristina Johnson resigned from our Board of Directors in connection with her confirmation as Under Secretary in the Department of Energy.

In addition, on May 22, 2009, Ursula M. Burns resigned from our Board of Directors in connection with her appointment as Chief Executive Officer of Xerox Corporation.

A copy of our press release announcing the departures is attached hereto as Exhibit 99.1.



ITEM 9.01.
FINANCIAL STATEMENTS AND EXHIBITS.

Exhibit No.
Description

99.1 
Press Release issued by Boston Scientific Corporation dated May 27, 2009.








 
 

 
SIGNATURE


Pursuant to the requirements of the Securities and Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
  BOSTON SCIENTIFIC CORPORATION  
       
Date:   May 27, 2009
By:
/s/ Lawrence J. Knopf  
    Lawrence J. Knopf  
    Senior Vice President and Deputy General Counsel  
       

 

 
 

 
 
 
 
 
 
 
 

 
EXHIBIT INDEX


Exhibit No.
Description

99.1 
Press Release issued by Boston Scientific Corporation dated May 27, 2009.